• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Med Sci Monit . Clinical Characteristics and Risk Factors of Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients in Beijing, China: A R

tetano

Editor, Senior Moderator
Med Sci Monit


. 2020 Sep 25;26:e925974.
doi: 10.12659/MSM.925974.
Clinical Characteristics and Risk Factors of Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients in Beijing, China: A Retrospective Study


Aibin Wang[SUP] 1 [/SUP], Guiju Gao[SUP] 1 [/SUP], Sa Wang[SUP] 1 [/SUP], Meiling Chen[SUP] 2 [/SUP], Fang Qian[SUP] 1 [/SUP], Weiming Tang[SUP] 3 [/SUP], Yanli Xu[SUP] 1 [/SUP], Rui Song[SUP] 1 [/SUP], Liwei Zhuang[SUP] 4 [/SUP], Xiaoyang Ma[SUP] 5 [/SUP], Tianwei Zhao[SUP] 1 [/SUP], Xiaodi Guo[SUP] 4 [/SUP], Wei Li[SUP] 4 [/SUP], Xudong Wang[SUP] 6 [/SUP], Baoliang Li[SUP] 6 [/SUP], Chun Hu[SUP] 6 [/SUP], Zhihai Chen[SUP] 1 [/SUP], Fujie Zhang[SUP] 1 [/SUP]



Affiliations

Abstract

BACKGROUND Coronavirus disease 2019 (COVID-19) is a new infectious disease, and acute respiratory syndrome (ARDS) plays an important role in the process of disease aggravation. The detailed clinical course and risk factors of ARDS have not been well described. MATERIAL AND METHODS We retrospectively investigated the demographic, clinical, and laboratory data of adult confirmed cases of COVID-19 in Beijing Ditan Hospital from Jan 20 to Feb 29, 2020 and compared the differences between ARDS cases and non-ARDS cases. Univariate and multivariate logistic regression methods were employed to explore the risk factors associated with ARDS. RESULTS Of the 130 adult patients enrolled in this study, the median age was 46.5 (34-62) years and 76 (58.5%) were male. ARDS developed in 26 (20.0%) and 1 (0.8%) death occurred. Fever occurred in 114 patients, with a median highest temperature of 38.5 (38-39)?C and median fever duration of 8 (3-11) days. The median time from illness onset to ARDS was 10 (6-13) days, the median time to chest CT improvement was 17 (14-21) days, and median time to negative nucleic acid test result was 27 (17-33) days. Multivariate regression analysis showed increasing odds of ARDS associated with age older than 65 years (OR=4.75, 95% CL1.26-17.89, P=0.021), lymphocyte counts [0.5-1?10⁹/L (OR=8.80, 95% CL 2.22-34.99, P=0.002); <0.5?10⁹/L(OR=36.23, 95% CL 4.63-2083.48, P=0.001)], and temperature peak ≥39.1?C (OR=5.35, 95% CL 1.38-20.76, P=0.015). CONCLUSIONS ARDS tended to occur in the second week of the disease course. Potential risk factors for ARDS were older age (>65 years), lymphopenia (≤1.0?10⁹/L), and temperature peak (≥39.1?C). These findings could help clinicians to predict which patients will have a poor prognosis at an early stage.
 
Back
Top Bottom